Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03469284 · ClinicalTrials.gov registry record · Phase 2
MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT03469284: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT03469284 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03469284, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
This phase II trial studies how well methylene blue works in treating patients with cancer and pain associated with oral mucositis. Methylene blue may relieve pain associated with oral mucositis.
Interventions
- OTHER Best Practice
- DRUG Methylene Blue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2022-02-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03469284
The ClinicalTrials.gov registry entry for NCT03469284 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Best Practice is the first listed.
NCT03469284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03469284 about?
NCT03469284 is a clinical study titled "MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)". This phase II trial studies how well methylene blue works in treating patients with cancer and pain associated with oral mucositis. Methylene blue may relieve pain associated with oral mucositis.
What is the current status of trial NCT03469284?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2019-02-28. Estimated completion is 2022-02-03.
What interventions are being tested in trial NCT03469284?
The interventions under investigation include: Best Practice (OTHER), Methylene Blue (DRUG).
Who is sponsoring clinical trial NCT03469284?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.